Literature DB >> 13963473

A collaborative study of measles vaccines in five United States communities. Preliminary report.

V F GUINEE.   

Abstract

Keywords:  MEASLES; VACCINES

Mesh：

Substances：

Year:  1963        PMID： 13963473      PMCID： PMC1254040          DOI： 10.2105/ajph.53.4.645

Source DB:  PubMed          Journal:  Am J Public Health Nations Health        ISSN： 0002-9572


× No keyword cloud information.
  11 in total

1.  Concentrated inactivated measlesvirus vaccine. Preparation and antigenic potency.

Authors:  J WARREN; M J GALLIAN
Journal:  Am J Dis Child       Date:  1962-03

2.  Inactivated measles virus vaccine. III. A field trial in young school children.

Authors:  W WINKELSTEIN; R JENSS; G E GRESHAM; D T KARZON; W E MOSHER
Journal:  JAMA       Date:  1962-02-10       Impact factor: 56.272

3.  Vaccination aginst measles. III. Clinical trial in British children.

Authors:  I R ALDOUS; B H KIRMAN; N BUTLER; A P GOFFE; G D LAURENCE; T M POLLOCK
Journal:  Br Med J       Date:  1961-11-11

4.  Serologic response of children to in-activated measles vaccine.

Authors:  C H CARTER; T J CONWAY; D CORNFELD; D G IEZZONI; C H KEMPE; C MOSCOVICI; L W RAUH; A J VIGNEC; J WARREN
Journal:  JAMA       Date:  1962-03-17       Impact factor: 56.272

5.  Studies of live attenuated measles virus vaccine in man. II. Appraisal of efficacy.

Authors:  M R HILLEMAN; J STOKES; E B BUYNAK; R WEIBEL; R HALENDA; H GOLDNER
Journal:  Am J Public Health Nations Health       Date:  1962-02

6.  Measles vaccine.

Authors:  S KARELITZ; F DESPOSITO; S GITTELSON; H GOLDMAN; A ROSS; F S MARKHAM; J M RUEGSEGGER; H R COX
Journal:  JAMA       Date:  1961-08-26       Impact factor: 56.272

7.  Studies with live attenuated measles-virus vaccine. II. Clinical and immunologic response of children in an open community.

Authors:  S KRESS; A E SCHLUEDERBERG; R B HORNICK; L J MORSE; J L COLE; E A SLATER; F R MCCRUMB
Journal:  Am J Dis Child       Date:  1961-06

8.  Studies on an attenuated measles-virus vaccine. I. Development and preparations of the vaccine: technics for assay of effects of vaccination.

Authors:  J F ENDERS; S L KATZ; M V MILOVANOVIC; A HOLLOWAY
Journal:  N Engl J Med       Date:  1960-07-28       Impact factor: 91.245

9.  The development and evaluation of an attenuated measles virus vaccine.

Authors:  S L KATZ; J F ENDERS; A HOLLOWAY
Journal:  Am J Public Health Nations Health       Date:  1962-02

10.  Inactivated measles virus vaccine. II. Prevention of natural and experimental measles with the vaccine.

Authors:  H A FELDMAN; A NOVACK; J WARREN
Journal:  JAMA       Date:  1962-02-10       Impact factor: 56.272
View more
  8 in total

1.  INACTIVATED MEASLES-VIRUS VACCINE.

Authors:  W H FOEGE; O S LELAND; C S MOLLOHAN; V A FULGINITI; D A HENDERSON; C H KEMPE
Journal:  Public Health Rep       Date:  1965-01       Impact factor: 2.792

2.  IMMUNIZATION WITH INACTIVATED MEASLES VIRUS VACCINE.

Authors:  S GARD; G CARLSTROEM; R LAGERCRANTZ; E NORRBY
Journal:  Arch Gesamte Virusforsch       Date:  1965

3.  A FOLLOW-UP STUDY OF IMMUNITY IN CHILDREN VACCINATED WITH LIVE ATTENUATED MEASLES VIRUS VACCINE.

Authors:  P HALONEN; P FORSSELL; A BACKMAN
Journal:  Arch Gesamte Virusforsch       Date:  1965

4.  Antiviral vaccine programs.

Authors: 
Journal:  Can Med Assoc J       Date:  1971-10-23       Impact factor: 8.262

5.  Immunizable disease occurrence and prevention in Seattle.

Authors:  R T Ravenholt; M J Levinski; M Johnson; A M Ravenholt
Journal:  Public Health Rep       Date:  1965-11       Impact factor: 2.792

6.  Serologic response of infants to combined inactivated measles-poliomyelitis vaccine.

Authors:  G C Brown; P L Kendrick
Journal:  Am J Public Health Nations Health       Date:  1965-11

7.  Complicated measles after killed vaccine.

Authors: 
Journal:  Can Med Assoc J       Date:  1970-10-10       Impact factor: 8.262

8.  CURRENT STATUS OF MEASLES AND ORAL POLIOVIRUS VACCINES.

Authors:  D R MACLEOD
Journal:  Can Med Assoc J       Date:  1964-11-21       Impact factor: 8.262
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.